NASDAQ:BIS ProShares UltraShort Nasdaq Biotechnology (BIS) Price, Holdings, & News $18.26 -0.27 (-1.46%) (As of 12/20/2024 05:15 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipShort InterestTrends About ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BIS alerts:Sign Up Key Stats Today's Range$17.92▼$18.3950-Day Range$14.35▼$18.5352-Week Range$14.05▼$21.10Volume14,382 shsAverage Volume14,141 shsMarket Capitalization$4.02 millionAssets Under Management$4.05 millionDividend Yield2.57%Net Expense Ratio0.95%Aggregate RatingN/A ETF OverviewProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.Read More… ProShares UltraShort Nasdaq Biotechnology ExpensesTypeBISHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.75%0.57%0.55%0.50%0.52%Other Expenses1.22%0.30%0.49%0.41%0.53%Total Expense1.97%0.70%0.71%0.64%0.71%Fee Waiver-1.02%-0.45%-0.51%-0.31%-0.56%Net Expense0.95%0.61%0.61%0.57%0.59% Receive BIS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address BIS ETF News HeadlinesBIS ProShares UltraShort Nasdaq Biotechnology ETFNovember 3, 2024 | seekingalpha.comNautilus Biotechnology (NASDAQ:NAUT) Stock Quotes, Forecast and News SummaryOctober 21, 2024 | benzinga.comWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."December 22, 2024 | DTI (Ad)Sana Biotechnology (NASDAQ:SANA) Stock, Short Interest ReportOctober 19, 2024 | benzinga.comPDS Biotechnology (NASDAQ:PDSB) Stock, Short Interest ReportOctober 5, 2024 | benzinga.comInvesting Strategies for Market CrashesSeptember 12, 2024 | msn.comSee More Headlines BIS ETF - Frequently Asked Questions How have BIS shares performed this year? ProShares UltraShort Nasdaq Biotechnology's stock was trading at $18.07 at the beginning of the year. Since then, BIS stock has increased by 1.1% and is now trading at $18.26. View the best growth stocks for 2024 here. When did ProShares UltraShort Nasdaq Biotechnology's stock split? ProShares UltraShort Nasdaq Biotechnology shares reverse split on Tuesday, August 18th 2020. The 1-4 reverse split was announced on Tuesday, August 4th 2020. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 17th 2020. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. Who are ProShares UltraShort Nasdaq Biotechnology's major shareholders? Top institutional investors of ProShares UltraShort Nasdaq Biotechnology include Jane Street Group LLC (4.78%). View institutional ownership trends. How do I buy shares of ProShares UltraShort Nasdaq Biotechnology? Shares of BIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of ProShares UltraShort Nasdaq Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some other companies that ProShares UltraShort Nasdaq Biotechnology investors own include Micron Technology (MU), Inovio Pharmaceuticals (INO), Sanofi (SNY), Intel (INTC), Meta Platforms (META), NVIDIA (NVDA) and Advanced Micro Devices (AMD). Fund Details IssuerProShares Fund NameProShares UltraShort Nasdaq Biotechnology Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:BIS Inception Date4/6/2010 Fund ManagerMichael Neches, Tarak Dave Webwww.proshares.com Phone+1-240-4976400Fund Focus Asset ClassEquity BenchmarkNasdaq Biotech Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings16 Fund Statistics Assets Under Management$4.05 million Average Daily Volume$14,929.30 Discount/Premium0.04% Leveraged-2.00 Administrator, Advisor and Custodian AdministratorJ.P. Morgan Investor Services Co. AdvisorProShare Advisors LLC CustodianJPMorgan Chase Bank, N.A. DistributorSEI Investments Distribution Co. Transfer AgentJPMorgan Chase Bank, N.A. TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume1 Put Options2 Call Options1 Short Interest8,400 shs Miscellaneous Outstanding Shares220,000Beta-1.41 Creation Unit50,000 Creation Fee$250.00 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report Top 8 BIS HoldingsNET OTHER ASSETS (LIABILITIES)Holding Weight: 0.00%TREASURY BILLHolding Weight: 0.00%NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NAHolding Weight: -7.73%NASDAQ BIO INDEX SWAP BNP PARIBASHolding Weight: -12.70%NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLCHolding Weight: -15.06%NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NAHolding Weight: -20.56%NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AGHolding Weight: -68.23%NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALEHolding Weight: -75.69%Full Holdings Details This page (NASDAQ:BIS) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraShort Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares UltraShort Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.